Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicted EC95 of Effect-site Concentration of Remifentanil for Preventing Cough After Laryngomicrosurgery From Propofol Anesthesia

NCT02973724 is registered in ClinicalTrials.gov with Ajou University School of Medicine as lead sponsor.

NCT NCT02973724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicted EC95 of Effect-site Concentration of Remifentanil for Preventing Cough After Laryngomicrosurgery From Propofol Anesthesia
Lead sponsor
Ajou University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2016
Completion date
June 30, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug usage